Shanghai Minwei Biotechnology Co., Ltd

Researchers are testing an experimental oral drug called MWN109 in adults with type 2 diabetes. The trial compares several doses of MWN109 against a placebo and against semaglutide tablets, a standard treatment, to see which works better at lowering blood sugar over 20 weeks. Abo…

This phase 2 trial tests an experimental injection called MWX203, given alone or with another drug called inclisiran, in people with mixed dyslipidemia whose blood fat levels stay high despite statin therapy. The study enrolls 216 adults in China who receive the injection under t…

This early-stage trial tests an investigational drug called MWN105, given as a weekly injection for 8 weeks, in Chinese adults who are overweight or obese but do not have diabetes. The study aims to see if the drug is safe and tolerable, and how it moves through the body. Partici…

Researchers are testing a single injection of MWX401 in healthy volunteers and people with mild high blood pressure. The trial aims to see if the drug is safe and how the body processes it. Participants receive one dose or a placebo, and doctors monitor blood pressure and side ef…

This early-stage study tests a new tablet called MWN109 in healthy adults who are overweight or have obesity. The main goal is to check if the drug is safe and how the body processes it. About 60 participants will receive either the drug or a placebo, and researchers will monitor…